Optimal management for people with severe spasticity

References

• KanPGoochJAminiASurgical treatment of spasticity in children: comparison of selective dorsal rhizotomy and intrathecal baclofen pump implantationChilds Nerv Sys200724239243
   Web of Science ®Google Scholar
• BakheitAMOBotulinum Toxin Treatment of Muscle SpasticityMilton Keynes, UKAuthorHouse2007
   Google Scholar
• RangMCerebral palsyMorrissyRLovell and Winter’s Pediatric OrthopedicsPhiladelphiaLippincott19903465506
   Google Scholar
• GreenNESwointkowskiMFSkeletal Trauma in Children4th edPhiladelphia, PASaunders, Elsevier2008
   Google Scholar
• GageJManaging spasticity in children with cerebral palsy requires a team approachA Pediatric Perspective200413316
   Google Scholar
• GoldwynAPountneyTTheoretical aspects of postural managementProceedings of the 19th International Seating SymposiumFebruary 27–March 1, 2003Orlando, FL
   Google Scholar
• CharlesPDGillCETaylorHMSpasticity treatment facilitates direct care delivery for adults with profound intellectual disabilityMov Disord201025446647320131401
   PubMed Web of Science ®Google Scholar
• DietzVSinkjaerTSpastic movement disorder: impaired reflex function and altered muscle mechanicsLancet Neurol2007672517638613
   PubMed Web of Science ®Google Scholar
• PaucaRYoungAParatonia and gegenhalten in childhood and senescenceClin Chiropr20121513134
   Google Scholar
• HobbelenJSKoopmansRTVerheyFRVan PeppenRPde BieRAParatonia: a Delphi procedure for consensus definitionJ Geriatr Phys Ther2006292505616914066
   PubMedGoogle Scholar
• HandleyAMedcalfPHellierKDuttaDMovement disorders after strokeAge Ageing200938326026619276093
   PubMed Web of Science ®Google Scholar
• AbdoWFVan de WarrenburgBPCBurnDJQuinnNPBloemBRThe clinical approach to movement disordersNat Rev Neurol20106293720057497
   PubMed Web of Science ®Google Scholar
• GhotbiNAnsariNNNaghdiSHassonSMeasurement of lower-limb muscle spasticity: intrarater reliability of modified modified Ashworth scaleJ Rehabil Res Dev2011481838821328165
   PubMed Web of Science ®Google Scholar
• YelnikAPSimonOParratteBGraciesJMHow to clinically assess and treat muscle overactivity in spastic paresisJ Rehabil Med20104280180720878038
   PubMed Web of Science ®Google Scholar
• DanBMottaFVlesJSHConsensus on the appropriate use of intrathecal baclofen (ITB) therapy in paediatric spasticityEur J Paediatr Neurol2010141192819541514
   PubMed Web of Science ®Google Scholar
• KimWHParkEYCausal relation between spasticity, strength, gross motor function, and functional outcome in children with cerebral palsy: a path analysisDev Med Child Neurol2011536873
   PubMed Web of Science ®Google Scholar
• MorrisCCurrent and future uses of the gross motor function classification system: the need to take account of other factors to explain functional outcomesDev Med Child Neurol201051121003
   Web of Science ®Google Scholar
• World Health OrganizationInternational classification of functioning, disability and health Available from: http://www.who.int/classifications/icf/enAccessed March 21, 2012
   Google Scholar
• PtyushkinPVidmarGBurgerHMarincekCUse of the international classification of functioning, disability, and health in traumatic brain injury rehabilitation: linking issues and general perspectivesAm J Phys Med Rehabil20129113S48S5422193310
   PubMed Web of Science ®Google Scholar
• WoodsideJMRosenbaumPLKingSMKingGAFamily-centered service: developing and validating a self-assessment tool for pediatric service providersChild Health Care200130237252
   Web of Science ®Google Scholar
• RosenbaumPFamily and quality of life: key elements in intervention in children with cerebral palsyDev Med Child Neurol2011536870
   PubMed Web of Science ®Google Scholar
• FirstWOvercoming disparities in US health careHealth Affairs20052444545115757929
   PubMed Web of Science ®Google Scholar
• ShiltJReevesSLaiLThe outcome of intrathecal baclofen treatment on spastic diplegia: preliminary results with a minimum of two year follow-upJ Pediatr Rehabil Med20081325526121791773
   PubMedGoogle Scholar
• KomanASmithBShiltJCerebral PalsyLancet20043631619163115145637
   PubMed Web of Science ®Google Scholar
• FarmerJSabbaghSSelective dorsal rhizotomies in the treatment of spasticity related to cerebral palsyChilds Nerv Sys2007239911002
   PubMed Web of Science ®Google Scholar
• NordmarkEJosenbyALLagergrenJAnderssonGStrömbladLWestbomILong-term outcomes five years after selective dorsal rhizotomyBMC Pediatr200885419077294
   PubMed Web of Science ®Google Scholar
• LangerakNLambertsRFieggenAPeterJPeacockWVaughanCSelective dorsal rhizotomy: long-term experience from Cape TownChilds Nerv Sys20072310031006
   PubMed Web of Science ®Google Scholar
• FarmerJSabbaghAJSelective dorsal rhizotomies in the treatment of spasticity related to cerebral palsyChilds Nerv Sys2007239911002
   PubMed Web of Science ®Google Scholar
• DarioATomeiGA benefit-risk assessment of baclofen in severe spinal spasticityDrug Saf2004271179981815350152
   PubMed Web of Science ®Google Scholar
• Schulte-MattlerWUse of Botulinum toxin A in adult neurological disorders: efficacy, tolerability, and safetyCNS Drugs200822972573818698873
   PubMed Web of Science ®Google Scholar
• KadyanVClairmontACEngleMColachisSCSevere trismus as a complication of cerebrovascular accident: a case reportArch Phys Med Rehabil200586359459515759251
   PubMed Web of Science ®Google Scholar
• PathakMSNguyenHTGrahamHKMooreAPManagement of spasticity in adults: practical application of botulinum toxin for the treatment of wrist and finger spasticity after a strokeEur J Neurol200613425016417597
   PubMed Web of Science ®Google Scholar
• ElovicEEsquenaziAAlterKKinJAlfaroAKaelinDChemodenervation and nerve blocks in the diagnosis and management of spasticityAm Acad Phys Med Rehabil20091842851
   Google Scholar
• RussmanBIntrathecal baclofenDev Med Child Neurol201052760119832881
   PubMed Web of Science ®Google Scholar
• ShiltJLaiLCabreraMFrinoJSmithBThe impact of intrathecal baclofen on the natural history of scoliosis in cerebral palsyJ Pediatr Orthop20082868468718724209
   PubMed Web of Science ®Google Scholar
• DarioATomeiGA benefit-risk assessment of baclofen in severe spinal spasticityDrug Saf2004271179981815350152
   PubMed Web of Science ®Google Scholar
• DvorakEKetchumNMcGuireJThe underutilization of intrathecal baclofen in poststroke spasticityTop Stroke Rehabil201118319520221642057
   PubMed Web of Science ®Google Scholar
• KrachLEKrielRLGilmartinRCHip status in cerebral palsy after one year of continuous intrathecal baclofen infusionPediatr Neurol2003303163168
   Web of Science ®Google Scholar
• Centers for Disease Control and PreventionStroke facts and statistics Available from: http://www.cdc.gov/stroke/stroke_facts.htmAccessed July 7, 2011
   Google Scholar
• GrahamHKSelberPMusculoskeletal aspects of cerebral palsyJ Bone Joint Surg Am200385-B157166
   Google Scholar
• ZivIBlackburnNRangMMuscle growth in normal and spastic miceDev Med Child Neurol19842694996698331
   PubMed Web of Science ®Google Scholar
• BakheitAThe use of botulinum toxin for the treatment of muscle spasticity in the first 2 years of lifeInt J Rehabil Res20103310410819574925
   PubMed Web of Science ®Google Scholar
• GorterJWVerschurenOvan RielLKetelaarMThe relationship between spasticity in young children (18 months of age) with cerebral palsy and their gross motor function developmentBMC Musculoskelet Disord20091010819728891
   PubMed Web of Science ®Google Scholar
• BalkrishnanRCamachoFTSmithBPCost impact of botulinum toxin therapy in medicaid-enrolled children with cerebral palsyJ South Orthop Assoc200227182
   Google Scholar
• GerstenPCAlbrightALJohnstoneGFIntrathecal baclofen infusion and subsequent orthopedic surgery in patients with spastic cerebral palsyJ Neurosurg199888100910139609295
   PubMed Web of Science ®Google Scholar